Artículo

Omicron Breakthrough Infection after Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response

Varese, AugustoIcon ; Mazzitelli, Bianca; Erra Diaz, Fernando AlbertoIcon ; Kjolhede, María Victoria; Ojeda, Diego SebastianIcon ; Vellicce, Alejandra Fabiana; Arto, Penélope; Cicero, Carla; Pascowsky, María; Figueras, Laura Victoria; Broese, Bárbara; Dávila, Rosa; Zarlenga, Rocío; Rivelli, Federico Martin; Verruno, Camila; Silenzi, Valeria; Beltran, Ivana Romina; Gamarnik, Andrea VanesaIcon ; Ceballos, AnaIcon ; Zala, Carlos; Badolati, Adelina; Geffner, Jorge RaúlIcon
Fecha de publicación: 11/2022
Editorial: Oxford University Press
Revista: Journal Of Infectious Diseases
ISSN: 0022-1899
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:

Resumen

Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is usually asymptomatic or mild and appears to be poorly immunogenic at least in unvaccinated individuals. Here, we found that health care workers vaccinated with 2 doses of Sputnik V and a booster dose of ChAdOx1 mount a vigorous neutralizing-Antibody response after Omicron breakthrough infection.
Palabras clave: COVID-19 , NEUTRALIZING ANTIBODIES , OMICRON , SARS-COV-2
 
Archivos asociados
Thumbnail
 
Tamaño: 2.588Kb
Formato: PDF
.
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/212995
URL: https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiac250/6611839?
DOI: http://dx.doi.org/10.1093/infdis/jiac250
Colecciones
Articulos(IIBBA)
Articulos de INST.DE INVEST.BIOQUIMICAS DE BS.AS(I)
Articulos(INBIRS)
Articulos de INSTITUTO DE INVESTIGACIONES BIOMEDICAS EN RETROVIRUS Y SIDA
Citación
Varese, Augusto; Mazzitelli, Bianca; Erra Diaz, Fernando Alberto; Kjolhede, María Victoria; Ojeda, Diego Sebastian; et al.; Omicron Breakthrough Infection after Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response; Oxford University Press; Journal Of Infectious Diseases; 226; 10; 11-2022; 1717-1720
Compartir
Altmétricas